Botulinum toxin type A, 4 Allergan Units/0.1ml, Powder for solution for injection
* The product is intended for professional use only.
Report an Adverse Event
Adverse Events must be reported to Allergan Aesthetics an AbbVie Company (tel: 2144165555, email: greekpv@abbvie.com) and
For events from the use of the medicinal product, for Greece: tel. 2132040337 or visit the websites: http://www.eof.gr, http://www.kitrinikarta.gr and for Cyprus: tel. 22 608607 or visit the website: www.moh.gov.cy/phs.